Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2026

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2026 of $1.34 per share on the company’s common stock. The dividend is payable on December 8, 2026 to shareholders of record at the close of business on November 24, 2026. The ex-dividend date is November 24, 2026.

About Johnson & Johnson

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20261013101430/en/

Media contact:
[email protected]

Investor contact:
[email protected]

Source: Johnson & Johnson

You May Also Be Interested In

• Erste Group Downgrades Johnson & Johnson (JNJ) to Hold
• Aeromax Acquires Loutech, Further Expanding Manufacturing Platform
• Form 8.3 - Eleco Plc